메뉴 건너뛰기
European Journal of Clinical Pharmacology
Volumn 65, Issue 1, 2009, Pages 101-103
High serum concentrations of ciclosporin related to administration of tigecycline
Author keywords

[No Author keywords available]
Indexed keywords

CYCLOSPORIN; GENTAMICIN; MEROPENEM; TIGECYCLINE; TOBRAMYCIN;
EID: 57849104346     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0557-8     Document Type: Letter
Times cited : (12)
References (12)
  • 1
    • 0021068930 scopus 로고
    • Cyclosporine Immunosuppression
    • DM Canafax NL Ascher 1983 Cyclosporine Immunosuppression Clin Pharm 6 515 524
    • (1983) Clin Pharm , vol.6 , pp. 515-524
    • Canafax, D.M.1    Ascher, N.L.2
  • 2
    • 0023508097 scopus 로고
    • Cyclosporine - Structure, pharmacokinetics, and therapeutic drug-monitoring
    • W Vine LD Bowers 1987 Cyclosporine - structure, pharmacokinetics, and therapeutic drug-monitoring CRC Crit Rev Clin Lab Sci 4 275 311
    • (1987) CRC Crit Rev Clin Lab Sci , vol.4 , pp. 275-311
    • Vine, W.1    Bowers, L.D.2
  • 3
    • 0025773120 scopus 로고
    • The immunosuppressive antagonism of low doses of FK506 and cyclosporine
    • A Vathsala S Goto N Yoshimura 1991 The immunosuppressive antagonism of low doses of FK506 and cyclosporine Transplantation 1 121 128
    • (1991) Transplantation , vol.1 , pp. 121-128
    • Vathsala, A.1    Goto, S.2    Yoshimura, N.3
  • 4
    • 0036054540 scopus 로고    scopus 로고
    • Distribution of cyclosporin in organ transplant recipients
    • F Akhlaghi AK Trull 2002 Distribution of cyclosporin in organ transplant recipients Clin Pharmacokinet 9 615 637
    • (2002) Clin Pharmacokinet , vol.9 , pp. 615-637
    • Akhlaghi, F.1    Trull, A.K.2
  • 5
    • 42149136030 scopus 로고    scopus 로고
    • Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: Impact on pharmacokinetics and clinical outcome
    • Suppl
    • M Mourad P Wallemacq M De Meyer 2008 Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome Transplantation 7 Suppl S19 S24
    • (2008) Transplantation , vol.7
    • Mourad, M.1    Wallemacq, P.2    De Meyer, M.3
  • 6
    • 0033818355 scopus 로고    scopus 로고
    • Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent
    • SJ Projan 2000 Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent Pharmacotherapy 9 219S 223S
    • (2000) Pharmacotherapy , vol.9
    • Projan, S.J.1
  • 7
    • 34548089728 scopus 로고    scopus 로고
    • Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects
    • M Hoffmann W DeMaio RA Jordan 2007 Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects Drug Metab Dispos 9 1543 1553
    • (2007) Drug Metab Dispos , vol.9 , pp. 1543-1553
    • Hoffmann, M.1    Demaio, W.2    Jordan, R.A.3
  • 8
    • 23844432244 scopus 로고    scopus 로고
    • The pharmacokinetic and pharmacodynamic profile of tigecycline
    • Meagher AK, Ambrose PG, Grasela TH et al (2005) The pharmacokinetic and pharmacodynamic profile of tigecycline. Clin Infect Dis 41:S333-S340
    • (2005) Clin Infect Dis , vol.41
    • Meagher, A.K.1    Ambrose, P.G.2    Grasela, T.H.3
  • 9
    • 33746616007 scopus 로고    scopus 로고
    • Tigecycline: A critical analysis
    • GE Stein WA Craig 2006 Tigecycline: a critical analysis Clin Infect Dis 4 518 524
    • (2006) Clin Infect Dis , vol.4 , pp. 518-524
    • Stein, G.E.1    Craig, W.A.2
  • 10
    • 34249001430 scopus 로고    scopus 로고
    • A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient
    • D Capone G Palmiero A Gentile 2007 A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient Curr Drug Metab 4 379 381
    • (2007) Curr Drug Metab , vol.4 , pp. 379-381
    • Capone, D.1    Palmiero, G.2    Gentile, A.3
  • 11
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • CA Naranjo U Busto EM Sellers 1981 A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 2 239 245
    • (1981) Clin Pharmacol Ther , vol.2 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3
  • 12
    • 2442433545 scopus 로고    scopus 로고
    • Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting
    • JR Nebeker P Barach MH Samore 2004 Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting Ann Intern Med 10 795 801
    • (2004) Ann Intern Med , vol.10 , pp. 795-801
    • Nebeker, J.R.1    Barach, P.2    Samore, M.H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.